Interpace Biosciences Statistics
Total Valuation
IDXG has a market cap or net worth of 3.32 million. The enterprise value is 5.97 million.
| Market Cap | 3.32M |
| Enterprise Value | 5.97M |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IDXG has 4.42 million shares outstanding. The number of shares has increased by 260.54% in one year.
| Current Share Class | 4.42M |
| Shares Outstanding | 4.42M |
| Shares Change (YoY) | +260.54% |
| Shares Change (QoQ) | +1,024.21% |
| Owned by Insiders (%) | 21.85% |
| Owned by Institutions (%) | 3.25% |
| Float | 3.46M |
Valuation Ratios
The trailing PE ratio is 2.22.
| PE Ratio | 2.22 |
| Forward PE | n/a |
| PS Ratio | 0.07 |
| PB Ratio | -5.70 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 0.65 |
| P/OCF Ratio | 0.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 0.60, with an EV/FCF ratio of 1.17.
| EV / Earnings | 0.83 |
| EV / Sales | 0.12 |
| EV / EBITDA | 0.60 |
| EV / EBIT | 0.68 |
| EV / FCF | 1.17 |
Financial Position
The company has a current ratio of 1.34
| Current Ratio | 1.34 |
| Quick Ratio | 1.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.39 |
| Debt / FCF | 0.76 |
| Interest Coverage | 16.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 41.41% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 151.70% |
| Revenue Per Employee | 434,802 |
| Profits Per Employee | 64,658 |
| Employee Count | 111 |
| Asset Turnover | 3.62 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.44% in the last 52 weeks. The beta is 0.69, so IDXG's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -44.44% |
| 50-Day Moving Average | 1.03 |
| 200-Day Moving Average | 1.72 |
| Relative Strength Index (RSI) | 42.82 |
| Average Volume (20 Days) | 14,368 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDXG had revenue of 48.26 million and earned 7.18 million in profits. Earnings per share was 0.33.
| Revenue | 48.26M |
| Gross Profit | 30.98M |
| Operating Income | 8.82M |
| Pretax Income | 7.91M |
| Net Income | 7.18M |
| EBITDA | 9.17M |
| EBIT | 8.82M |
| Earnings Per Share (EPS) | 0.33 |
Balance Sheet
The company has 1.20 million in cash and 3.85 million in debt, giving a net cash position of -2.65 million or -0.60 per share.
| Cash & Cash Equivalents | 1.20M |
| Total Debt | 3.85M |
| Net Cash | -2.65M |
| Net Cash Per Share | -0.60 |
| Equity (Book Value) | -582,000 |
| Book Value Per Share | -0.13 |
| Working Capital | 2.98M |
Cash Flow
In the last 12 months, operating cash flow was 5.94 million and capital expenditures -848,000, giving a free cash flow of 5.09 million.
| Operating Cash Flow | 5.94M |
| Capital Expenditures | -848,000 |
| Free Cash Flow | 5.09M |
| FCF Per Share | 1.15 |
Margins
Gross margin is 64.20%, with operating and profit margins of 18.28% and 15.83%.
| Gross Margin | 64.20% |
| Operating Margin | 18.28% |
| Pretax Margin | 16.38% |
| Profit Margin | 15.83% |
| EBITDA Margin | 18.99% |
| EBIT Margin | 18.28% |
| FCF Margin | 10.55% |
Dividends & Yields
IDXG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -260.54% |
| Shareholder Yield | -260.54% |
| Earnings Yield | 216.35% |
| FCF Yield | 153.47% |
Stock Splits
The last stock split was on January 15, 2020. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 15, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |